Barry Investment Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-39,554
Closed -$9.67M 103
2026
Q1
$9.67M Sell
39,554
-73
-0.2% -$17K 2.13% 15
2025
Q4
$8.2M Sell
39,627
-4,138
-9% -$818K 1.83% 16
2025
Q3
$8.11M Sell
43,765
-2,109
-5% -$361K 1.87% 15
2025
Q2
$7.01M Buy
45,874
+1,177
+3% +$181K 1.74% 17
2025
Q1
$7.41M Sell
44,697
-750
-2% -$117K 1.97% 14
2024
Q4
$6.57M Sell
45,447
-167
-0.4% -$25.9K 2.11% 14
2024
Q3
$7.39M Sell
45,614
-48
-0.1% -$7.65K 2.26% 14
2024
Q2
$6.67M Sell
45,662
-485
-1% -$72.1K 2.25% 14
2024
Q1
$7.3M Sell
46,147
-785
-2% -$125K 2.43% 13
2023
Q4
$7.36M Sell
46,932
-1,512
-3% -$232K 2.49% 13
2023
Q3
$7.55M Sell
48,444
-306
-0.6% -$50.5K 2.72% 12
2023
Q2
$8.07M Sell
48,750
-1,236
-2% -$199K 2.72% 12
2023
Q1
$7.75M Sell
49,986
-37
-0.1% -$5.97K 2.54% 17
2022
Q4
$8.84M Sell
50,023
-1,180
-2% -$204K 2.79% 11
2022
Q3
$8.37M Sell
51,203
-438
-0.8% -$74.1K 2.87% 12
2022
Q2
$9.17M Sell
51,641
-2,413
-4% -$430K 2.75% 11
2022
Q1
$9.58M Sell
54,054
-644
-1% -$110K 2.54% 13
2021
Q4
$9.36M Sell
54,698
-273
-0.5% -$44.7K 2.47% 16
2021
Q3
$8.88M Sell
54,971
-825
-1% -$141K 2.46% 11
2021
Q2
$9.19M Sell
55,796
-123
-0.2% -$20.4K 2.46% 10
2021
Q1
$9.19M Sell
55,919
-507
-0.9% -$82K 2.53% 9
2020
Q4
$8.88M Buy
56,426
+312
+0.6% +$46K 2.62% 10
2020
Q3
$8.35M Sell
56,114
-613
-1% -$90.7K 2.87% 10
2020
Q2
$7.98M Buy
56,727
+660
+1% +$96.2K 2.82% 10
2020
Q1
$7.35M Buy
56,067
+47,978
+593% +$6.81M 3.64% 8
2019
Q4
$1.18M Sell
8,089
-1,137
-12% -$154K 0.41% 32
2019
Q3
$1.19M Buy
9,226
+48
+0.5% +$6.32K 0.43% 31
2019
Q2
$1.28M Buy
9,178
+439
+5% +$60.8K 0.44% 33
2019
Q1
$1.22M Sell
8,739
-62
-0.7% -$8.3K 0.38% 36
2018
Q4
$1.14M Buy
8,801
+136
+2% +$19K 0.43% 37
2018
Q3
$1.2M Buy
8,665
+10
+0.1% +$1.33K 0.4% 33
2018
Q2
$1.05M Buy
8,655
+553
+7% +$69K 0.4% 34
2018
Q1
$1.04M Buy
8,102
+111
+1% +$15K 0.39% 34
2017
Q4
$1.12M Sell
7,991
-132
-2% -$18.4K 0.41% 34
2017
Q3
$1.06M Buy
8,123
+33
+0.4% +$4.38K 0.39% 34
2017
Q2
$1.07M Sell
8,090
-39
-0.5% -$4.97K 0.4% 34
2017
Q1
$1.01M Sell
8,129
-45
-0.6% -$5.38K 0.38% 36
2016
Q4
$942K Sell
8,174
-1,287
-14% -$149K 0.33% 40
2016
Q3
$1.12M Buy
9,461
+36
+0.4% +$4.37K 0.38% 40
2016
Q2
$1.14M Buy
9,425
+36
+0.4% +$4.09K 0.44% 38
2016
Q1
$1.02M Buy
9,389
+37
+0.4% +$3.83K 0.32% 43
2015
Q4
$961K Buy
9,352
+38
+0.4% +$3.82K 0.31% 47
2015
Q3
$869K Sell
9,314
-160
-2% -$15.5K 0.28% 46
2015
Q2
$923K Buy
9,474
+24
+0.3% +$2.4K 0.93% 21
2015
Q1
$951K Buy
9,450
+3,802
+67% +$387K 0.29% 46
2014
Q4
$591K Buy
+5,648
New +$595K 0.19% 49

Other funds holding JNJ

Barry Investment Advisors's JNJ Position: Q2 2026 in Review

Barry Investment Advisors sold out of Johnson & Johnson (JNJ) in Q2 2026, closing a stake of 39,554 shares — an estimated $9.67M sold.

Barry Investment Advisors first reported a position in JNJ in Q4 2014 and held it in 46 quarters. The position peaked at $9.67M in Q1 2026. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Barry Investment Advisors reported no remaining Johnson & Johnson position as of Q2 2026 after selling out during the quarter.
  • Barry Investment Advisors sold 39,554 Johnson & Johnson shares in Q2 2026, an estimated $9.67M.
  • Barry Investment Advisors first reported a position in Johnson & Johnson in Q4 2014 and held it in 46 quarters.
  • Barry Investment Advisors's Johnson & Johnson position peaked at $9.67M in Q1 2026.
  • 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Barry Investment Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.